Mary DeRome, Senior Director of Medical Communications and Education at the Multiple Myeloma Research Foundation, gets answers to frequently asked questions about myeloma treatments, including autologous stem cell transplantation and maintenance therapy, and about how minimal residual disease testing is used as a treatment goal from Dr. Gurbakhash Kaur (Assistant Professor of Internal Medicine, (Southwestern Medical Center; Dallas, Texas), nurse practitioner Sonia Patel (Southwestern Medical Center; Dallas, Texas), and myeloma patient Don O’Connor.
Dr. Kaur, Ms. Patel, and Mr. O’Connor provide insights on a range of topics relating to newly diagnosed multiple myeloma, such as...
00:43 Induction Therapy Options + Supportive Care
23:58 Autologous Stem Cell Transplantation
33:47 Maintenance Therapy and Minimal Residual Disease Testing

This session is supported by Adaptive, Bristol Myers Squibb, Genentech, GSK, Janssen, Karyopharm, and Takeda.

If you have additional questions, call our MMRF Patient Navigation Center at 18888416673.